Pyrrolidine compounds having thromboxane A.sub.2 receptor antagonistic activity and thromboxane A.sub.2 synthase inhibiting activity
US5296494A · kind A · utility
6Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 18, 1992 |
| Grant date | Mar 22, 1994 |
| Priority date | — |
| Expiry date | Dec 18, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I): ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, m, n, and R are as defined in the Specification. Medicinal products containing the same are useful in the treatment or prevention of thrombotic afflictions due to their thromboxane A.sub.2 receptor antagonistic activity and their thromboxane A.sub.2 synthase inhibitory activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.